External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

CMSC 2023

-
Coming soon
04:20 PM
Duration 20mins Gaylord Rockies Resort & Convention Center Summit 6-7
Long-term Efficacy of Satralizumabâ–¼ in Adults With Aquaporin-4-IgG-seropositive (AQP4-IgG+) Neuromyelitis Optica Spectrum Disorder (NMOSD): Results from SAkuraMoon
Anthony Traboulsee, Ingo Kleiter, Jacqueline Palace, Kazuo Fujihara, Albert Saiz, Ivana Vodopivec, Gaelle Klingelschmitt, Carole Marcillat, Jeffrey L Bennett

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar